Symbols / MEDP Stock $416.84 -0.69% Medpace Holdings, Inc.

Healthcare • Diagnostics & Research • United States • NMS
MEDP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Dr. August James Troendle M.D.
Exch · Country NMS · United States
Market Cap 11.90B
Enterprise Value 11.48B
Income 460.40M
Sales 2.68B
FCF (ttm) 490.74M
Book/sh 20.95
Cash/sh 22.85
Employees 6,300
Insider 10d —
IPO Aug 11, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 26.20
Forward P/E 22.46
PEG 2.58
P/S 4.44
P/B 19.90
P/C —
EV/EBITDA 19.43
EV/Sales 4.29
Quick Ratio 0.78
Current Ratio 0.85
Debt/Eq 24.42
LT Debt/Eq —
EPS (ttm) 15.91
EPS next Y 18.56
EPS Growth 16.60%
Revenue Growth 26.50%
EPS Gr Q/Q 8.10%
Rev Gr Q/Q —
Earnings (next) 2026-07-20
Earnings (prior) 2026-04-22
ROA 17.47%
ROE 77.25%
ROIC —
Gross Margin 71.90%
Oper. Margin 20.03%
Profit Margin 17.19%
Shs Outstand 28.56M
Shs Float 23.00M
Insider Own 19.42%
Instit Own 88.20%
Short Float 6.74%
Short Ratio 3.32
Short Interest 1.55M
52W High 628.92
vs 52W High -33.72%
52W Low 284.48
vs 52W Low 46.53%
Beta 1.19
Impl. Vol. 58.30%
Rel Volume 0.14
Avg Volume 392.38K
Volume 53.46K
Target (mean) $442.83
Tgt Median $456.00
Tgt Low $329.00
Tgt High $495.00
# Analysts 12
Recom None
Prev Close $419.75
Price $416.84
Change -0.69%
About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$442.83
Mean price target
2. Current target
$417.13
Latest analyst target
3. DCF / Fair value
$309.29
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$417.13
Low
$329.00
High
$495.00
Mean
$442.83

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-24 main Barclays Equal-Weight → Equal-Weight $450
2026-04-24 main BMO Capital Market Perform → Market Perform $400
2026-04-24 main RBC Capital Outperform → Outperform $484
2026-04-24 main Baird Outperform → Outperform $477
2026-03-06 up Barclays Underweight → Equal-Weight $500
2026-03-03 init RBC Capital — → Outperform $522
2026-02-18 up TD Cowen Sell → Hold $419
2026-02-13 up Jefferies Hold → Buy $560
2026-02-11 main Barclays Underweight → Underweight $500
2026-02-11 main Truist Securities Hold → Hold $539
2026-02-11 main Leerink Partners Market Perform → Market Perform $485
2025-12-15 main Barclays Underweight → Underweight $525
2025-11-13 init BMO Capital — → Market Perform $600
2025-10-27 main Truist Securities Hold → Hold $555
2025-10-24 main TD Cowen Sell → Sell $462
2025-10-24 main Barclays Underweight → Underweight $485
2025-10-24 main Mizuho Outperform → Outperform $655
2025-10-17 main Mizuho Outperform → Outperform $575
2025-10-02 down Barclays Equal-Weight → Underweight $425
2025-09-09 main Jefferies Hold → Hold $450
News
RSS: Latest MEDP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-24 BRADY KEVIN M. Chief Financial Officer — 7,000 $138.87 $972,090
2026-04-24 EWALD STEPHEN P General Counsel — 3,500 $138.87 $486,045
2026-03-31 CARLEY BRIAN T Director — 36 — —
2026-03-31 MCCARTHY CORNELIUS P. III Director — 29 — —
2026-03-31 KRAFT ROBERT O Director — 33 — —
2026-03-18 BURWIG SUSAN ELIZABETH Officer — 12,000 $166.73 $2,000,760
2026-03-17 GEIGER JESSE J President — 31,707 $138.87 $4,403,151
2026-03-17 GEIGER JESSE J President — 31,707 $455.30 $14,436,197
2026-02-17 EWALD STEPHEN P General Counsel — 3,500 $138.87 $486,045
2026-02-13 BURWIG SUSAN ELIZABETH Officer — 10,984 $107.93 $1,185,503
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,530.23
+19.97%
2,109.05
+11.84%
1,885.84
+29.17%
1,460.00
Operating Revenue
2,530.23
+19.97%
2,109.05
+11.84%
1,885.84
+29.17%
1,460.00
Cost Of Revenue
1,769.62
+21.81%
1,452.75
+6.71%
1,361.34
+32.48%
1,027.56
Reconciled Cost Of Revenue
1,769.62
+21.81%
1,452.75
+6.71%
1,361.34
+32.48%
1,027.56
Gross Profit
760.62
+15.89%
656.30
+25.13%
524.50
+21.29%
432.44
Operating Expense
225.68
+7.76%
209.44
+11.59%
187.68
+22.08%
153.74
Selling General And Administration
197.56
+9.64%
180.18
+11.67%
161.35
+22.79%
131.40
Total Expenses
1,995.30
+20.04%
1,662.18
+7.31%
1,549.02
+31.13%
1,181.30
Operating Income
534.93
+19.71%
446.87
+32.67%
336.82
+20.86%
278.70
Total Operating Income As Reported
534.93
+19.71%
446.87
+32.67%
336.82
+20.86%
278.70
EBITDA
563.06
+18.26%
476.12
+31.11%
363.15
+20.63%
301.04
Normalized EBITDA
570.79
+19.76%
476.62
+30.55%
365.08
+22.85%
297.18
Reconciled Depreciation
28.12
-3.85%
29.25
+11.10%
26.33
+17.85%
22.34
EBIT
534.93
+19.71%
446.87
+32.67%
336.82
+20.86%
278.70
Total Unusual Items
-7.73
-1458.67%
-0.50
+74.29%
-1.93
-149.99%
3.86
Total Unusual Items Excluding Goodwill
-7.73
-1458.67%
-0.50
+74.29%
-1.93
-149.99%
3.86
Net Income
451.12
+11.56%
404.39
+42.99%
282.81
+15.26%
245.37
Pretax Income
542.38
+13.96%
475.92
+41.78%
335.68
+18.67%
282.86
Net Non Operating Interest Income Expense
12.78
-48.87%
25.00
+5222.13%
-0.49
+83.20%
-2.90
Net Interest Income
12.78
-48.87%
25.00
+5222.13%
-0.49
+83.20%
-2.90
Other Income Expense
-5.34
-231.61%
4.06
+719.24%
-0.66
-109.27%
7.07
Other Non Operating Income Expenses
2.39
-47.43%
4.55
+257.30%
1.27
-60.30%
3.21
Gain On Sale Of Security
-7.73
-1458.67%
-0.50
+74.29%
-1.93
-149.99%
3.86
Tax Provision
91.25
+27.56%
71.54
+35.30%
52.87
+41.02%
37.49
Tax Rate For Calcs
0.00
+12.00%
0.00
-5.06%
0.00
+18.80%
0.00
Tax Effect Of Unusual Items
-1.30
-1645.71%
-0.07
+75.59%
-0.30
-159.38%
0.51
Net Income Including Noncontrolling Interests
451.12
+11.56%
404.39
+42.99%
282.81
+15.26%
245.37
Net Income From Continuing Operation Net Minority Interest
451.12
+11.56%
404.39
+42.99%
282.81
+15.26%
245.37
Net Income From Continuing And Discontinued Operation
451.12
+11.56%
404.39
+42.99%
282.81
+15.26%
245.37
Net Income Continuous Operations
451.12
+11.56%
404.39
+42.99%
282.81
+15.26%
245.37
Normalized Income
457.56
+13.03%
404.81
+42.32%
284.43
+17.52%
242.02
Net Income Common Stockholders
451.12
+11.57%
404.34
+43.07%
282.62
+15.26%
245.21
Otherunder Preferred Stock Dividend
0.00
-100.00%
0.04
-76.96%
0.19
+21.66%
0.16
Diluted EPS
15.28
+20.98%
12.63
+42.23%
8.88
+21.98%
7.28
Basic EPS
15.64
+19.75%
13.06
+41.96%
9.20
+21.53%
7.57
Basic Average Shares
28.85
-6.82%
30.96
+0.76%
30.72
-5.14%
32.39
Diluted Average Shares
29.53
-7.77%
32.01
+0.54%
31.84
-5.43%
33.67
Diluted NI Availto Com Stockholders
451.12
+11.57%
404.34
+43.07%
282.62
+15.26%
245.21
Amortization
0.95
-34.44%
1.44
-34.38%
2.20
-34.40%
3.35
Amortization Of Intangibles Income Statement
0.95
-34.44%
1.44
-34.38%
2.20
-34.40%
3.35
Depreciation Amortization Depletion Income Statement
28.12
-3.85%
29.25
+11.10%
26.33
+17.85%
22.34
Depreciation And Amortization In Income Statement
28.12
-3.85%
29.25
+11.10%
26.33
+17.85%
22.34
Depreciation Income Statement
27.18
-2.27%
27.81
+15.25%
24.13
+27.07%
18.99
Total Other Finance Cost
-12.78
+48.87%
-25.00
-5222.13%
0.49
-83.20%
2.90
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,975.47
-5.97%
2,100.87
+26.80%
1,656.83
+22.50%
1,352.49
Current Assets
989.62
-3.85%
1,029.23
+73.32%
593.83
+77.81%
333.96
Cash Cash Equivalents And Short Term Investments
497.05
-25.75%
669.44
+172.74%
245.45
+768.38%
28.27
Cash And Cash Equivalents
497.05
-25.75%
669.44
+172.74%
245.45
+768.38%
28.27
Receivables
402.08
+35.63%
296.44
-0.66%
298.40
+17.76%
253.40
Accounts Receivable
376.75
+29.43%
291.10
+5.50%
275.93
+29.44%
213.17
Receivables Adjustments Allowances
-0.03
0.00
+100.00%
-0.01
+95.88%
-0.17
Other Receivables
25.35
+374.14%
5.35
-76.21%
22.48
-44.38%
40.41
Prepaid Assets
—
—
—
—
Other Current Assets
90.50
+42.85%
63.35
+26.75%
49.98
-4.43%
52.29
Total Non Current Assets
985.85
-8.01%
1,071.64
+0.81%
1,063.00
+4.37%
1,018.53
Net PPE
248.87
-1.35%
252.26
-4.95%
265.39
+6.62%
248.92
Gross PPE
372.14
+5.98%
351.13
+1.84%
344.79
+10.85%
311.03
Accumulated Depreciation
-123.27
-24.68%
-98.87
-24.51%
-79.40
-27.83%
-62.12
Properties
0.00
0.00
0.00
0.00
Land And Improvements
5.14
+2.15%
5.03
+4.12%
4.83
+100.54%
2.41
Buildings And Improvements
40.45
+155.79%
15.81
-3.68%
16.42
+20.78%
13.59
Machinery Furniture Equipment
142.61
+5.77%
134.83
+2.43%
131.63
+15.88%
113.59
Construction In Progress
12.77
-39.66%
21.17
+194.72%
7.18
-31.72%
10.52
Other Properties
171.17
-1.79%
174.29
-5.65%
184.73
+8.08%
170.92
Goodwill And Other Intangible Assets
695.82
-0.14%
696.76
-0.21%
698.21
-0.31%
700.40
Goodwill
662.40
+0.00%
662.40
+0.00%
662.40
+0.00%
662.40
Other Intangible Assets
33.42
-2.75%
34.37
-4.03%
35.81
-5.79%
38.01
Non Current Deferred Assets
19.22
-80.85%
100.36
+34.83%
74.44
+54.81%
48.08
Non Current Deferred Taxes Assets
19.22
-80.85%
100.36
+34.83%
74.44
+54.81%
48.08
Other Non Current Assets
21.94
-1.42%
22.25
-10.88%
24.97
+18.18%
21.13
Total Liabilities Net Minority Interest
1,516.40
+18.90%
1,275.32
+16.16%
1,097.88
+13.64%
966.11
Current Liabilities
1,343.75
+21.66%
1,104.55
+19.39%
925.13
+15.14%
803.47
Payables And Accrued Expenses
356.38
+39.54%
255.41
+2.57%
249.01
+44.77%
172.00
Payables
28.14
-13.48%
32.53
+2.07%
31.87
-3.63%
33.07
Accounts Payable
28.14
-13.48%
32.53
+2.07%
31.87
-3.63%
33.07
Current Accrued Expenses
328.24
+47.27%
222.88
+2.64%
217.14
+56.30%
138.93
Pensionand Other Post Retirement Benefit Plans Current
80.14
-5.64%
84.93
+12.01%
75.82
+6.50%
71.20
Current Debt And Capital Lease Obligation
—
—
—
50.00
Current Debt
—
—
—
50.00
Current Deferred Liabilities
854.39
+20.24%
710.59
+26.92%
559.86
+20.99%
462.73
Current Deferred Revenue
854.39
+20.24%
710.59
+26.92%
559.86
+20.99%
462.73
Other Current Liabilities
52.83
-1.49%
53.63
+32.62%
40.44
-14.95%
47.55
Total Non Current Liabilities Net Minority Interest
172.65
+1.10%
170.77
-1.15%
172.75
+6.22%
162.64
Long Term Debt And Capital Lease Obligation
113.64
-9.97%
126.23
-11.18%
142.12
+2.34%
138.87
Long Term Capital Lease Obligation
113.64
-9.97%
126.23
-11.18%
142.12
+2.34%
138.87
Non Current Deferred Liabilities
1.35
-24.72%
1.80
-25.12%
2.40
+124.67%
1.07
Non Current Deferred Taxes Liabilities
1.35
-24.72%
1.80
-25.12%
2.40
+124.67%
1.07
Other Non Current Liabilities
57.66
+34.92%
42.73
+51.43%
28.22
+24.32%
22.70
Stockholders Equity
459.07
-44.39%
825.54
+47.70%
558.95
+44.66%
386.39
Common Stock Equity
459.07
-44.39%
825.54
+47.70%
558.95
+44.66%
386.39
Capital Stock
0.28
-7.19%
0.31
-0.65%
0.31
-0.32%
0.31
Common Stock
0.28
-7.19%
0.31
-0.65%
0.31
-0.32%
0.31
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
28.44
-7.36%
30.70
-0.40%
30.82
-1.09%
31.16
Ordinary Shares Number
28.37
-7.38%
30.63
-0.40%
30.75
-1.09%
31.09
Treasury Shares Number
0.07
-0.64%
0.07
-0.71%
0.07
-1.40%
0.07
Additional Paid In Capital
935.83
+10.87%
844.05
+5.15%
802.68
+4.14%
770.79
Retained Earnings
-459.98
-5732.19%
8.17
+103.68%
-221.65
+38.40%
-359.83
Gains Losses Not Affecting Retained Earnings
-4.91
+66.72%
-14.74
-46.38%
-10.07
+18.72%
-12.39
Treasury Stock
12.16
-0.65%
12.23
-0.71%
12.32
-1.40%
12.50
Other Equity Adjustments
-4.91
+66.72%
-14.74
-46.38%
-10.07
+18.72%
-12.39
Total Equity Gross Minority Interest
459.07
-44.39%
825.54
+47.70%
558.95
+44.66%
386.39
Total Capitalization
459.07
-44.39%
825.54
+47.70%
558.95
+44.66%
386.39
Working Capital
-354.12
-370.13%
-75.32
+77.26%
-331.30
+29.44%
-469.51
Invested Capital
459.07
-44.39%
825.54
+47.70%
558.95
+28.09%
436.39
Total Debt
113.64
-9.97%
126.23
-11.18%
142.12
-24.75%
188.87
Net Debt
—
—
—
21.73
Capital Lease Obligations
113.64
-9.97%
126.23
-11.18%
142.12
+2.34%
138.87
Net Tangible Assets
-236.75
-283.83%
128.78
+192.48%
-139.25
+55.65%
-314.02
Tangible Book Value
-236.75
-283.83%
128.78
+192.48%
-139.25
+55.65%
-314.02
Line Of Credit
—
—
0.00
-100.00%
50.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
713.22
+17.15%
608.82
+40.48%
433.37
+11.68%
388.05
Cash Flow From Continuing Operating Activities
713.22
+17.15%
608.82
+40.48%
433.37
+11.68%
388.05
Net Income From Continuing Operations
451.12
+11.56%
404.39
+42.99%
282.81
+15.26%
245.37
Depreciation Amortization Depletion
28.12
-3.85%
29.25
+11.10%
26.33
+17.85%
22.34
Depreciation
27.18
-2.27%
27.81
+15.25%
24.13
+27.07%
18.99
Amortization Cash Flow
0.95
-34.44%
1.44
-34.38%
2.20
-34.40%
3.35
Depreciation And Amortization
28.12
-3.85%
29.25
+11.10%
26.33
+17.85%
22.34
Amortization Of Intangibles
0.95
-34.44%
1.44
-34.38%
2.20
-34.40%
3.35
Other Non Cash Items
22.14
+15.82%
19.11
-14.48%
22.35
+40.68%
15.89
Stock Based Compensation
34.79
+36.34%
25.51
+24.36%
20.52
-4.18%
21.41
Deferred Tax
80.77
+403.29%
-26.63
-6.03%
-25.12
-9.14%
-23.01
Deferred Income Tax
80.77
+403.29%
-26.63
-6.03%
-25.12
-9.14%
-23.01
Change In Working Capital
96.28
-38.75%
157.18
+47.61%
106.49
+0.41%
106.06
Change In Receivables
-106.22
-4837.51%
2.24
+104.64%
-48.28
+27.85%
-66.92
Change In Prepaid Assets
-27.10
-124.16%
-12.09
-504.89%
2.99
+129.35%
-10.18
Change In Payables And Accrued Expense
99.71
+616.48%
13.92
-83.26%
83.13
+41.12%
58.91
Change In Accrued Expense
97.08
+475.07%
16.88
-79.43%
82.08
+56.41%
52.48
Change In Payable
2.63
+188.67%
-2.96
-382.11%
1.05
-83.66%
6.43
Change In Account Payable
2.63
+188.67%
-2.96
-382.11%
1.05
-83.66%
6.43
Change In Other Working Capital
155.04
-11.16%
174.52
+99.40%
87.52
-37.55%
140.14
Change In Other Current Liabilities
-25.16
-17.53%
-21.41
-13.43%
-18.87
-18.71%
-15.90
Investing Cash Flow
-31.14
-10.00%
-28.31
+18.25%
-34.63
+10.62%
-38.74
Cash Flow From Continuing Investing Activities
-31.14
-10.00%
-28.31
+18.25%
-34.63
+10.62%
-38.74
Net PPE Purchase And Sale
-31.36
+14.21%
-36.55
+0.27%
-36.65
+0.63%
-36.88
Purchase Of PPE
-31.36
+14.21%
-36.55
+0.27%
-36.65
+0.63%
-36.88
Capital Expenditure
-31.36
+14.21%
-36.55
+0.27%
-36.65
+0.63%
-36.88
Capital Expenditure Reported
—
—
—
—
Net Other Investing Changes
0.22
-97.38%
8.24
+308.12%
2.02
+208.37%
-1.86
Financing Cash Flow
-860.39
-458.66%
-154.01
+15.68%
-182.64
+76.46%
-775.77
Cash Flow From Continuing Financing Activities
-860.39
-458.66%
-154.01
+15.68%
-182.64
+76.46%
-775.77
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-50.00
-200.00%
50.00
Issuance Of Debt
0.00
0.00
-100.00%
105.00
-67.61%
324.20
Repayment Of Debt
0.00
0.00
+100.00%
-155.00
+43.47%
-274.20
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
0.00
0.00
-100.00%
105.00
-67.61%
324.20
Short Term Debt Payments
0.00
0.00
+100.00%
-155.00
+43.47%
-274.20
Net Short Term Debt Issuance
0.00
0.00
+100.00%
-50.00
-200.00%
50.00
Net Common Stock Issuance
-917.39
-440.06%
-169.87
-17.95%
-144.02
+83.01%
-847.85
Common Stock Payments
-917.39
-440.06%
-169.87
-17.95%
-144.02
+83.01%
-847.85
Repurchase Of Capital Stock
-917.39
-440.06%
-169.87
-17.95%
-144.02
+83.01%
-847.85
Proceeds From Stock Option Exercised
57.00
+259.45%
15.86
+39.37%
11.38
-48.46%
22.07
Changes In Cash
-178.31
-141.81%
426.50
+97.36%
216.10
+150.67%
-426.47
Effect Of Exchange Rate Changes
5.92
+335.68%
-2.51
-332.28%
1.08
+116.45%
-6.57
Beginning Cash Position
669.44
+172.74%
245.45
+768.38%
28.27
-93.87%
461.30
End Cash Position
497.05
-25.75%
669.44
+172.74%
245.45
+768.38%
28.27
Free Cash Flow
681.87
+19.15%
572.27
+44.25%
396.73
+12.97%
351.17
Interest Paid Supplemental Data
0.00
-100.00%
0.17
-94.40%
3.06
+4.12%
2.94
Income Tax Paid Supplemental Data
39.72
-52.47%
83.57
+9.45%
76.35
+52.21%
50.16
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category